Abivax Files July 2024 6-K Report
Ticker: AAVXF · Form: 6-K · Filed: Jul 16, 2024 · CIK: 1956827
| Field | Detail |
|---|---|
| Company | Abivax S.A. (AAVXF) |
| Form Type | 6-K |
| Filed Date | Jul 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, regulatory-filing, foreign-private-issuer
TL;DR
Abivax files its monthly 6-K report, confirming 20-F filing and Paris HQ.
AI Summary
Abivax S.A. filed a Form 6-K on July 16, 2024, reporting for the month of July 2024. The company, based in Paris, France, is a pharmaceutical preparations company and is submitting its report under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. Abivax is filing its annual reports under cover of Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Abivax S.A.'s ongoing compliance and reporting obligations as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer, providing standard reporting information without new material events.
Key Players & Entities
- Abivax S.A. (company) — Registrant
- Paris, France (location) — Company Headquarters
- July 16, 2024 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Cover
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer submitted pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of July 2024.
Where is Abivax S.A. located?
Abivax S.A.'s principal executive offices are located at 7-11 boulevard Haussmann, 75009 Paris, France.
Does Abivax file its annual reports under Form 20-F or 40-F?
Abivax indicates by check mark that it files its annual reports under cover of Form 20-F.
What is the Commission File Number for Abivax S.A.?
The Commission File Number for Abivax S.A. is 001-41842.
What is the SIC code for Abivax S.A.?
The Standard Industrial Classification (SIC) code for Abivax S.A. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 189 words · 1 min read · ~1 pages · Grade level 12.2 · Accepted 2024-07-16 06:00:10
Filing Documents
- f6k_071624.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 21KB
- 0001171843-24-003960.txt ( ) — 27KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Abivax SA (Registrant) Date: July 15, 2024 /s/ Marc de Garidel Marc de Garidel Chief Executive Officer